rethinkPeptides Search
Menu
Home / Research library
Research citation

The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus.

RPEP-005471999Nyholm, B; Orskov, L; Hove, K Y; Gravholt, C H; Møller, N; Alberti, K G; Moyses, C; Kolterman, O; Schmitz, O
evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus.

Metabolism: clinical and experimental, 48(7), 935-41

View on PubMed ↗

Citation

Nyholm, B; Orskov, L; Hove, K Y; Gravholt, C H; Møller, N; Alberti, K G; Moyses, C; Kolterman, O; Schmitz, O. (1999). The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus.. Metabolism: clinical and experimental, 48(7), 935-41.